Medivo to Demonstrate Correlation of Actionable Lab Data to Rx Success at PMSA

Share Article

Poster Presentation at Pharmaceutical Management Science Association (PMSA) Meeting Demonstrates the Use of Lab Data Strategies to Accelerate New Product Adoption Using Lab Results Linked to Treatment Dispensed

News Image
Medivo’s poster demonstrates the impact of our lab data solutions in getting the right treatment to the right patient at the right time.

Medivo, Inc., a leader in lab data analytics, will present a scientific poster at the Pharmaceutical Management Science Association (PMSA) Annual Conference, which is being held April 20-22, 2015, at the Hyatt Regency Crystal City in Arlington, Virginia.

The poster illustrates findings from three case studies based on Hepatitis C Virus (HCV) results derived from Medivo’s CLEAR™ (Clinical Lab Engine for Actionable Results) Data Solutions tools.

Medivo’s CLEAR Data Solutions allow brand marketers to develop intelligent physician profiling and early insights based on the Medivo Lab Value Exchange™ (LVX™), a nationwide database of standardized and anonymized lab test results. CLEAR Trigger is Medivo’s solution for informing sales representatives about physicians considering patient treatment options in real time, while CLEAR Targeter informs real-time targeting of physicians and CLEAR Profiler informs sales planning and physician profiling.

Medivo’s poster, entitled “Accelerating New Product Adoption Using Lab Results Linked to Treatment Dispensed: HCV, A Case Study,” showcases the positive impact of de-identified, analyzed patient-level lab data in the development of more effective pharmaceutical marketing programs.

“Medivo’s poster demonstrates the impact of our lab data solutions in getting the right treatment to the right patient at the right time,” said Dr. Jason Bhan, Chief Medical Officer and Co-Founder of Medivo. “Our solutions allow for physician education opportunities in time to make a difference. As a practicing physician myself, I know how important it is to be well informed about available treatment options.”

“Medivo’s data solutions provide insights that make it possible for our pharmaceutical clients to impact treatment decisions before they are made,” added Tatiana Sorokina, Sr. Manager, Advanced Analytics and Insights at Medivo. “Our lab dataset is unique in that it enables the identification of clinicians caring for relevant patients using lab result values.”

Medivo will be exhibiting at the PMSA Annual Conference at Booth #6, as well as hosting an event on Tuesday, April 21st, where Medivo’s team will review the methodology in greater detail. PMSA attendees who are interested in attending Medivo’s special event can RSVP at the following web address: http://info.medivo.com/pmsa-2015.

About Medivo
Medivo is a health data analytics company that unlocks the power of lab data to improve health. Medivo is the largest source of lab data in the U.S., with access to over 100M patients through its nationwide network of partner labs. Medivo enables life science companies to build clinical intelligence to optimize their sales and marketing initiatives, while enabling labs to realize the full value of their data assets and to gain value with their customers through Medivo’s Lab Solutions. Founded in 2010 by healthcare entrepreneurs, Medivo’s investors include Safeguard Scientifics, Inc. (NYSE:SFE) and Merck Global Health Innovation Fund (GHIF). For more information, visit http://www.medivo.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allison Keeley
Medivo
+1 917-945-8502
Email >
Visit website